Chlorite in the treatment of neurodegenerative disease
US8029826B2 · kind B2 · utility
10Cited by
4References
4Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 17, 2006 |
| Grant date | Oct 4, 2011 |
| Priority date | — |
| Expiry date | Jun 9, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/18
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention features methods of treating a macrophage-associated neurodegenerative disease such as amyotrophic lateral sclerosis (ALS), Alzheimer's disease (AD), or multiple sclerosis (MS) in a subject by administering chlorite in an amount effective to decrease blood immune cell activation. The invention also features methods of monitoring therapy by assessing blood immune cell activation before and after therapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.